Loomis Sayles & Co. L P decreased its position in CME Group Inc. (NASDAQ:CME – Free Report) by 18.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 393 shares of the financial services provider’s stock after selling 91 shares during the quarter. Loomis Sayles & Co. L P’s holdings in CME Group were worth $91,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in CME. SJS Investment Consulting Inc. raised its holdings in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after buying an additional 97 shares in the last quarter. Dunhill Financial LLC boosted its stake in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares in the last quarter. Financial Life Planners acquired a new position in shares of CME Group during the 4th quarter valued at about $32,000. Knuff & Co LLC bought a new position in shares of CME Group in the 4th quarter valued at approximately $33,000. Finally, Fortitude Family Office LLC grew its holdings in CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on CME. Morgan Stanley boosted their price objective on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 19th. Oppenheimer boosted their target price on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research note on Friday, February 14th. Finally, Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price on the stock in a report on Monday, March 10th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average price target of $238.93.
Insider Buying and Selling
In related news, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares in the company, valued at approximately $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 over the last quarter. Corporate insiders own 0.30% of the company’s stock.
CME Group Stock Performance
CME opened at $262.22 on Monday. The stock’s 50 day simple moving average is $249.65 and its 200-day simple moving average is $235.87. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market cap of $94.49 billion, a PE ratio of 27.12, a P/E/G ratio of 6.76 and a beta of 0.53. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $267.91.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.91%. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is presently 51.71%.
CME Group declared that its Board of Directors has approved a stock repurchase program on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- What Does a Stock Split Mean?
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 03/24 – 03/28
- The 3 Best Fintech Stocks to Buy Now
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.